Stay updated on RX-5902 in Triple Negative Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the RX-5902 in Triple Negative Breast Cancer Clinical Trial page.

Latest updates to the RX-5902 in Triple Negative Breast Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedRevision metadata updated: added v3.5.0 and removed v3.4.3.SummaryDifference0.1%

- Check26 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check54 days agoChange DetectedAdded Revision: v3.4.2. Removed the lapse-in-funding notice about data currency.SummaryDifference0.4%

- Check61 days agoChange DetectedAdded a government funding lapse notice with NIH Clinical Center status and a site revision to v3.4.1, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check68 days agoChange DetectedAdded a Show glossary option and new metadata items (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0). Removed the previous labels (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4).SummaryDifference0.2%

- Check82 days agoChange DetectedThe site revision label was updated from v3.3.3 to v3.3.4; no study content, endpoints, eligibility criteria, or navigation were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to RX-5902 in Triple Negative Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RX-5902 in Triple Negative Breast Cancer Clinical Trial page.